İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

MEHMET KADİR ERDOĞAN

DOÇENT

BİNGÖL ÜNİVERSİTESİ FEN-EDEBİYAT FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Moleküler Biyoloji ve Genetik

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 55
  • Proje 0
  • Kitap 0
  • Bildiri 37
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 5 Q2 31 Q3 5 Q4 0
WoS (JCR) Q1 11 Q2 15 Q3 13 Q4 4
TR Index 9 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 16
Ort. yüzdelik 73.1%
Üst %1 payı 0.0%
Üst %10 payı 33.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 55 yayın

Scopus (SJR)
Q1 5 Q2 31 Q3 5 Q4 0
WoS (JCR)
Q1 11 Q2 15 Q3 13 Q4 4
TR Index
9 makale

Makale listesi

  1. 2026 The effect of PARP and PLK1 dual inhibition on the expression of important protein signaling pathways, DNA damage, and molecular docking scores against MCF-7 and MDA-MB-231 breast cancer cell lines Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-04127-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.3%
  2. 2026 Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-04240-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 2.1%
  3. 2026 Cytotoxic and apoptotic effects of Fe, Cu, and Ag nanoparticles synthesized with sage (Salvia officinalis) extract on rainbow trout gonad cell line Aquatic Toxicology DOI 10.1016/j.aquatox.2026.107903 YÖKSİS SJR Q1 JCR Q1 OpenAlex 43.3%
  4. 2026 The effect of PARP and PLK1 dual inhibition on the expression of important protein signaling pathways, DNA damage, and molecular docking scores against MCF-7 and MDA-MB-231 breast cancer cell lines Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-04127-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.3%
  5. 2026 Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-04240-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 2.1%
  6. 2026 Synergistic Antitumor Effects of Paclitaxel Combined with PDE5 Inhibitor Avanafil on Glioma U373 Cells Korean Journal of Chemical Engineering DOI 10.1007/s11814-026-00704-4 YÖKSİS SJR Q2 JCR Q2 OpenAlex 23.0%
  7. 2026 Synergistic Antitumor Effects of Paclitaxel Combined with PDE5 Inhibitor Avanafil on Glioma U373 Cells Korean Journal of Chemical Engineering DOI 10.1007/s11814-026-00704-4 YÖKSİS SJR Q2 JCR Q2 OpenAlex 23.0%
  8. 2025 Deciphering the Anticancer, Antioxidant, Enzyme Inhibition Potentials, and Phytochemical Compositions of Some Endemic Centaurea Species Chemistry & Biodiversity DOI 10.1002/cbdv.202403185 YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.2%
  9. 2025 Phenolic Compounds: Investigating Their Anti-Carbonic Anhydrase, Anti-Cholinesterase, Anticancer, Anticholinergic, and Antiepileptic Properties Through Molecular Docking, MM-GBSA, and Dynamics Analyses Korean Journal of Chemical Engineering DOI 10.1007/s11814-025-00401-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 97.1%
  10. 2025 Gallic Acid Enhances Olaparib-Induced Cell Death and Attenuates Olaparib Resistance in Human Osteosarcoma U2OS Cell Line Current Issues in Molecular Biology DOI 10.3390/cimb47020104 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.3%
  11. 2025 Synergistic Anticancer Effects of Bleomycin and Hesperidin Combination on A549 Non-Small Cell Lung Cancer Cells: Antiproliferative, Apoptotic, Anti-Angiogenic, and Autophagic Insights Pharmaceuticals DOI 10.3390/ph18020254 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.1%
  12. 2025 Evaluation of the Anticancer Potential of S. euphratica, S. staminea, and S. trichoclada in Colon Cancer: Monotherapy and Combination with Cisplatin Journal of Medical Science DOI 10.20883/medical.e1469 YÖKSİS JCR Q3 OpenAlex 86.0%
  13. 2025 Synergistic Anticancer Activity of Quercetin Combined with Luteolin in MCF-7 Breast Cancer Cells via Induction of Apoptosis Türk Tarım ve Doğa Bilimleri Dergisi DOI 10.30910/turkjans.1597186 YÖKSİS TR Index OpenAlex 1.1%
  14. 2025 Assessment of cytotoxic, apoptotic, enzyme inhibitory, and antioxidant properties, and phytochemical characterization of ethanolic extract from Cionura erecta Food Bioscience DOI 10.1016/j.fbio.2025.106082 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.2%
  15. 2025 Assessment of cytotoxic, apoptotic, enzyme inhibitory, and antioxidant properties, and phytochemical characterization of ethanolic extract from Cionura erecta Food Bioscience DOI 10.1016/j.fbio.2025.106082 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.2%
  16. 2025 Deciphering the Anticancer, Antioxidant, Enzyme Inhibition Potentials, and Phytochemical Compositions of Some Endemic Centaurea Species Chemistry & Biodiversity DOI 10.1002/cbdv.202403185 YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.2%
  17. 2025 Phenolic Compounds: Investigating Their Anti-Carbonic Anhydrase, Anti-Cholinesterase, Anticancer, Anticholinergic, and Antiepileptic Properties Through Molecular Docking, MM-GBSA, and Dynamics Analyses Korean Journal of Chemical Engineering DOI 10.1007/s11814-025-00401-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 97.1%
  18. 2024 Comparison of Anticancer, Antioxidant, Enzyme Inhibitory Effects and Phytochemical Contents Between Edible Lettuce (Lactuca sativa) and a New Wild Species (Lactuca anatolica) CHEMISTRY & BIODIVERSITY DOI 10.1002/cbdv.202400552 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 90.7%
  19. 2024 Verbascum gimgimense an Endemic Turkish Plant: Evaluation of In Vitro Anticancer, Antioxidant, Enzyme Inhibitory Activities, and Phytochemical Profile Cell Biochemistry and Function DOI 10.1002/cbf.70023 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.6%
  20. 2024 Comparison of Anticancer, Antioxidant, Enzyme Inhibitory Effects and Phytochemical Contents Between Edible Lettuce (Lactuca sativa) and a New Wild Species (Lactuca anatolica) Chemistry & Biodiversity DOI 10.1002/cbdv.202400552 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 90.7%

Akademisyenlere dön